Pulp and periapical disease as a risk factor for osteonecrosis of the jaw: a national cohort-based study in Korea
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: This longitudinal cohort study aimed to evaluate the relationship between osteonecrosis of the jaw and pulp and periapical disease in patients who were administered bisphosphonates. Methods: Using data from a nationwide cohort, we examined the association among dental caries, pulp and periapical disease, and osteonecrosis of the jaw in women aged >50 years who received bisphosphonates for more than 1 year between 2002 and 2015. Because of ambiguities in the diagnosis of osteonecrosis of the jaw in population-based data, we operationally defined and categorized the condition into established and potential osteonecrosis of the jaw. Results: Pulp and periapical disease significantly increased the development of both established and potential osteonecrosis of the jaw (hazard ratio, 2.21; 95% confidence interval, 1.40–3.48; and hazard ratio, 2.22; 95% confidence interval, 1.65–2.98, respectively). Root canal treatment did not have any influence on the development of osteonecrosis of the jaw. Conclusions: Pulp and periapical disease may be a major risk factor for osteonecrosis of the jaw. The study findings suggest that patients should undergo regular dental examinations to detect pulp and periapical disease before or during the administration of bisphosphonates and that root canal treatment should be considered to decrease the risk of osteonecrosis of the jaw.
Abstract
Purpose: This longitudinal cohort study aimed to evaluate the relationship between osteonecrosis of the jaw and pulp and periapical disease in patients who were administered bisphosphonates. Methods: Using data from a nationwide cohort, we examined the association among dental caries, pulp and periapical disease, and osteonecrosis of the jaw in women aged >50 years who received bisphosphonates for more than 1 year between 2002 and 2015. Because of ambiguities in the diagnosis of osteonecrosis of the jaw in population-based data, we operationally defined and categorized the condition into established and potential osteonecrosis of the jaw. Results: Pulp and periapical disease significantly increased the development of both established and potential osteonecrosis of the jaw (hazard ratio, 2.21; 95% confidence interval, 1.40–3.48; and hazard ratio, 2.22; 95% confidence interval, 1.65–2.98, respectively). Root canal treatment did not have any influence on the development of osteonecrosis of the jaw. Conclusions: Pulp and periapical disease may be a major risk factor for osteonecrosis of the jaw. The study findings suggest that patients should undergo regular dental examinations to detect pulp and periapical disease before or during the administration of bisphosphonates and that root canal treatment should be considered to decrease the risk of osteonecrosis of the jaw.
참고문헌 (38)
- Drake MT, "Bisphosphonates : mechanism of action and role in clinical practice", Mayo Clin Proc, 83, pp.1032~1045 (2008)
- Migliorati CA, "Treatment of bisphosphonates-associated osteonecrosis", Clin Cases Miner Bone Metab, 4, pp.62~68 (2007)
- Christodoulou C, "Combination of bisphosphonates and antiangiogenic factors induces osteonecrosis of the jaw more frequently than bisphosphonates alone", Oncology, 76, pp.209~211 (2009)
- Capocci M, "Medication-related osteonecrosis of the jaws(MRONJ)and quality of life evaluation : a pilot study", Clin Ter, 168, pp.e253~e257 (2017)
- Kim KM, "medication related osteonecrosis of the jaw : 2015 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons", J Bone Metab, 22, pp.151~165 (2015)
- Jeong HG, "Risk factors of osteonecrosis of the jaw after tooth extraction in osteoporotic patients on oral bisphosphonates", Imaging Sci Dent, 47, pp.45~50 (2017)
- Soundia A, "Osteonecrosis of the jaws(ONJ)in mice after extraction of teeth with periradicular disease", Bone, 90, pp.133~141 (2016)
- Chiu WY, "The influence of alendronate and tooth extraction on the incidence of osteonecrosis of the jaw among osteoporotic subjects", PLoS One, 13, pp.e0196419~ (2018)
- Yamazaki T, "Increased incidence of osteonecrosis of the jaw after tooth extraction in patients treated with bisphosphonates : a cohort study", Int J Oral Maxillofac Implants, 41, pp.1397~1403 (2012)
- Khan AA, "Case-based review of osteonecrosis of the jaw(ONJ)and application of the international recommendations for management from the International Task Force on ONJ", J Clin Densitom, 20, pp.8~24 (2017)
- Jadu F, "A retrospective study assessing the incidence, risk factors and comorbidities of pamidronate-related necrosis of the jaws in multiple myeloma patients", Ann Oncol, 18, pp.2015~2019 (2007)
- Badros A, "Osteonecrosis of the jaw in multiple myeloma patients : clinical features and risk factors", J Clin Oncol, 24, pp.945~952 (2006)
- Barasch A, "Risk factors for osteonecrosis of the jaws : a case-control study from the CONDOR Dental PBRN", Tex Dent J, 130, pp.299~307 (2013)
- Utreja A, "Dental extraction as a risk factor for bisphosphonate related osteonecrosis of the jaw in cancer patients : an update", Odontostomatol Trop, 36, pp.38~46 (2013)
- He L, "Pathogenesis and multidisciplinary management of medication-related osteonecrosis of the jaw", Int J Oral Sci, 12, pp.30~ (2020)
- Kobayashi Y, "Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice", J Bone Miner Metab, 28, pp.165~175 (2010)
- Song M, "Preexisting periapical inflammatory condition exacerbates tooth extraction-induced bisphosphonate-related osteonecrosis of the jaw lesions in mice", J Endod, 42, pp.1641~1646 (2016)
- Cheong S, "Bisphosphonate uptake in areas of tooth extraction or periapical disease", J Oral Maxillofac Surg, 72, pp.2461~2468 (2014)
- Kang B, "Periapical disease and bisphosphonates induce osteonecrosis of the jaws in mice", J Bone Miner Res, 28, pp.1631~1640 (2013)
- Vahtsevanos K, "Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw", J Clin Oncol, 27, pp.5356~5362 (2009)
- Seong SC, "Cohort profile : the National Health Insurance Service-National Health Screening Cohort(NHIS-HEALS)in Korea", BMJ Open, 7, pp.e016640~ (2017)
- Gong X, "Skeletal site-specific effects of zoledronate on in vivo bone remodeling and in vitro BMSCs osteogenic activity", Sci Rep, 7, pp.36129~ (2017)
- Lim SS, "Differential modulation of zoledronate and etidronate in osseous healing of an extracted socket and tibia defect", Oral Surg Oral Med Oral Pathol Oral Radiol, 123, pp.8~19 (2017)
- Kamberi B, "Prevalence of apical periodontitis and endodontic treatment in a Kosovar adult population", BMC Oral Health, 11, pp.32~ (2011)
- Chala S, "Prevalence of apical periodontitis and factors associated with the periradicular status", Acta Odontol Scand, 69, pp.355~359 (2011)
- Kassebaum NJ, "Global burden of untreated caries : a systematic review and metaregression", J Dent Res, 94, pp.650~658 (2015)
- Jansson L, "The influence of endodontic infection on progression of marginal bone loss in periodontitis", J Clin Periodontol, 22, pp.729~734 (1995)
- Seltzer S, "Pulpitis-induced interradicular periodontal changes in experimental animals", J Periodontol, 38, pp.124~129 (1967)
- Ayangco L, "Development and treatment of retrograde peri-implantitis involving a site with a history of failed endodontic and apicoectomy procedures : a series of reports", Int J Oral Maxillofac Implants, 16, pp.412~417 (2001)
- Sussman HI, "Localized osteomyelitis secondary to endodontic-implant pathosis. A case report", J Periodontol, 64, pp.306~310 (1993)
- Zhou W, "Endodontic treatment of teeth induces retrograde peri-implantitis", Clin Oral Implants Res, 20, pp.1326~1332 (2009)
- Ruggiero SL, "American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update", J Oral Maxillofac Surg, 72, pp.1938~1956 (2014)
- Rupel K, "A systematic review of therapeutical approaches in bisphosphonates-related osteonecrosis of the jaw(BRONJ)", Oral Oncol, 50, pp.1049~1057 (2014)
- Lee SH, "Use of bisphosphonates and the risk of osteonecrosis among cancer patients : a systemic review and meta-analysis of the observational studies", Support Care Cancer, 22, pp.553~560 (2014)
- Bonacina R, "Preventive strategies and clinical implications for bisphosphonate-related osteonecrosis of the jaw : a review of 282 patients", J Can Dent Assoc, 77, pp.b147~ (2011)
- Dimopoulos MA, "Reduction of osteonecrosis of the jaw(ONJ)after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid", Ann Oncol, 20, pp.117~120 (2009)
- Migliorati CA, "Medication-related osteonecrosis of the jaws", J Natl Cancer Inst Monogr, 2019, pp.lgz009~ (2019)
- Aghaloo TL, "RANKL inhibitors induce osteonecrosis of the jaw in mice with periapical disease", J Bone Miner Res, 29, pp.843~854 (2014)